McKesson and CD&R to Acquire Option Care Health for $5.8 Billion

Key Facts

McKesson Corporation and private equity firm CD&R have struck a $5.8 billion deal to acquire infusion services provider Option Care Health. The Financial Times reported that the acquisition targets a healthcare services provider trading below its historical valuation multiples, expanding McKesson's footprint in the specialized infusion market.

MCK closed at $915.45 on October 5, 2026, while OPCH shares ended the same session at $23.37. The deal represents a significant move by the healthcare distributor and the private equity firm to consolidate their presence in the healthcare services sector.